概要
October 17-18: Meeting
Preconference Short Course 1: Quality Stream
Preconference Short Course 2: ICH Clinical Safety and Efficacy
The Short Courses have been endorsed as ICH Recognized Training Programs.
The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global health care product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing to key regulatory and clinical considerations for biologics and biosimilars, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.
As Canada celebrates its 150 years of Confederation in 2017, the DIA Annual Canadian Meeting will explore how Canada’s past has set the stage for future innovation in its health care ecosystem. Bringing together key stakeholders from the pharmaceutical and device industries, regulatory agencies, and academia, this Meeting will analyze the relevant challenges and opportunities for professionals working in drug and device development in Canada.
This year’s meeting will feature preconference short courses, plenary sessions, multi-track breakout sessions tailored to the beginner, intermediate, and advanced level professional, and multiple networking opportunities.
NEW! This year the DIA Annual Canadian Meeting will be co-located with DIA's Canadian Pharmacovigilance and Risk Management Conference. Maximize your education and time by attending both!
DIA's Canadian Health Care Content Roundup
Learn more about Canada's innovative health care policies and how they will be addressed at this year's meeting!
View ToolkitHighlights
- Two ICH Short Courses — Learn the latest ICH updates from industry and regulatory experts
- Designed to advance understanding of targeted ICH guidelines
- Case-based learning, presentations, and open discussion
- Networking/Exhibitor reception
- Three concurrent breakout sessions allowing you to customize your learning experience
- Discounted entertainment and dining through our partners at the Ottawa Convention and Visitors Bureau
- Use of the DIA Global App to plan your schedule, view exhibiting companies, and network with your peers
- Co-located with our other premier DIA Canadian event: Canadian Pharmacovigilance and Risk Management Strategies Conference
プログラム委員会
-
Marilena Bassi, MA Senior Executive Director, Therapeutic Products Directorate
Health Canada, Canada -
Deirdre Cozier Director, Global Regulatory Affairs
Pharmascience, Canada -
Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
AbbVie Corporation, Canada -
Laura Durno, MS, MSc Acting Chief, Viral Vaccines Division
Biologics and Genetic Therapies Directorate, Health Canada, Canada -
Karen Feltmate President
Redstone Health Group, Inc., Canada -
Lorella Garofalo, PhD Head of Regulatory Sciences
Pfizer Canada ULC, Canada -
Maggie Graham Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate
Health Canada, Canada -
Keith McIntosh Executive Director, Scientific & Regulatory Affairs
Innovative Medicines Canada, Canada -
Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada -
Matthew Ryan Senior Policy Analyst; Policy, Planning and International Affairs Directorate
Health Canada, Canada
